Cardiology
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Looking for a medical communications company? MedWrite International specializes in delivering global strategic medical marketing communications. Visit MedWrite's site to learn more.
This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 10.
Journal Scan: Long-Term Effects of a Very Low-Carbohydrate Diet and a Low-Fat Diet on Mood and Cognitive Function (Arch Intern Med 2009;169:1873-1880.)
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Subjects (ages 24-64 years) were randomized to an energy-restricted diet, isocaloric, very low-carbohydrate, high-fat diet or a high-carbohydrate, low-fat diet for 1 year. Subjects were excluded if they had a history of liver, cardiovascular, peripheral, respiratory, or gastrointestinal disease; dia. . .
Source: Cardiosource - November 16, 2009 Category: Cardiology Source Type: organizations
CVN: News from AHA 09Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
AHA 2009 Meeting Coverage: Daily Wrap-up / Monday
Source: Cardiosource - November 16, 2009 Category: Cardiology Source Type: organizations
Prognostic Implications of Myocardial Perfusion Single-Photon Emission Computed Tomography in the Elderly.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusions-Stress MPS effectively stratifies CD risk in elderly patients and may identify optimal post-MPS therapy. CD rates after normal MPS are low in all subsets in relative terms compared with the age-matched US population.
PMID: 19917890 [PubMed - as supplied by publisher]
Source: Circulation - November 16, 2009 Category: Cardiology Authors: Hachamovitch R, Kang X, Amanullah AM, Abidov A, Hayes SW, Friedman JD, Cohen I, Thomson LE, Germano G, Berman DS Tags: Circulation Source Type: journals
Vascular Endothelial-Specific Dimethylarginine Dimethylaminohydrolase-1-Deficient Mice Reveal That Vascular Endothelium Plays an Important Role in Removing Asymmetric Dimethylarginine.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusions-Our study demonstrates that DDAH1 is highly expressed in vascular endothelium and that endothelial DDAH1 plays an important role in regulating blood pressure. In the context that asymmetric methylarginines are broadly produced by many type of cells, the strong DDAH1 expression in vascular endothelium demonstrates for the first time that vascular endothelium can be an important site to actively dispose of toxic biochemical molecules produced by other types of cells.
PMID: 19917889 [PubMed - as supplied by publisher]
Source: Circulation - November 16, 2009 Category: Cardiology Authors: Hu X, Xu X, Zhu G, Atzler D, Kimoto M, Chen J, Schwedhelm E, Lüneburg N, Böger RH, Zhang P, Chen Y Tags: Circulation Source Type: journals
Effects of Statin Therapy According to Plasma High-Sensitivity C-Reactive Protein Concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). A Retrospective Analysis.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusion-In this retrospective hypothesis-generating study, we found a significant interaction between hs-CRP and the effect of rosuvastatin for most end points whereby rosuvastatin treatment was associated with better outcomes in patients with hs-CRP >/=2.0 mg/L. Clinical Trial Registration Information-URL: http://www.clinicaltrials.gov. Unique identifier: NCT00206310.
PMID: 19917888 [PubMed - as supplied by publisher]
Source: Circulation - November 16, 2009 Category: Cardiology Authors: McMurray JJ, Kjekshus J, Gullestad L, Dunselman P, Hjalmarson A, Wedel H, Lindberg M, Waagstein F, Grande P, Hradec J, Kamensky G, Korewicki J, Kuusi T, Mach F, Ranjith N, Wikstrand J, Tags: Circulation Source Type: journals
Impact of Implantable Cardioverter-Defibrillator, Amiodarone, and Placebo on the Mode of Death in Stable Patients With Heart Failure. Analysis From the Sudden Cardiac Death in Heart Failure Trial.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusions-ICD therapy reduced cardiac mortality and sudden death presumed to be ventricular tachyarrhythmic in SCD-HeFT and had no effect on heart failure mortality. Amiodarone had no effect on all-cause mortality or its cause-specific components. Clinical Trial Registration Information-URL: http://www.clinicaltrials.gov. Unique identifier: NCT00000609.
PMID: 19917887 [PubMed - as supplied by publisher]
Source: Circulation - November 16, 2009 Category: Cardiology Authors: Packer DL, Prutkin JM, Hellkamp AS, Mitchell LB, Bernstein RC, Wood F, Boehmer JP, Carlson MD, Frantz RP, McNulty SE, Rogers JG, Anderson J, Johnson GW, Walsh MN, Poole JE, Mark DB, Lee KL, Bardy GH Tags: Circulation Source Type: journals
Priming With Angiopoietin-1 Augments the Vasculogenic Potential of the Peripheral Blood Stem Cells Mobilized With Granulocyte Colony-Stimulating Factor Through a Novel Tie2/Ets-1 Pathway.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusions-The short-term priming with COMP-Ang1 may be a feasible and promising option to activate (mob)PBSCs by enhancing differentiation and adhesiveness and to improve the efficacy of cell therapy for ischemic diseases.
PMID: 19917886 [PubMed - as supplied by publisher]
Source: Circulation - November 16, 2009 Category: Cardiology Authors: Kim MS, Lee CS, Hur J, Cho HJ, Jun SI, Kim TY, Lee SW, Suh JW, Park KW, Lee HY, Kang HJ, Lee DS, Koh GY, Nakagami H, Morishita R, Park YB, Kim HS Tags: Circulation Source Type: journals
Validation of Magnetic Resonance Myocardial Perfusion Imaging With Fractional Flow Reserve for the Detection of Significant Coronary Heart Disease.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusion-MRMPI can detect functionally significant coronary heart disease with excellent sensitivity, specificity, and positive and negative predictive values compared with FFR.
PMID: 19917885 [PubMed - as supplied by publisher]
Source: Circulation - November 16, 2009 Category: Cardiology Authors: Watkins S, McGeoch R, Lyne J, Steedman T, Good R, McLaughlin MJ, Cunningham T, Bezlyak V, Ford I, Dargie HJ, Oldroyd KG Tags: Circulation Source Type: journals
High Residual Platelet Reactivity After Clopidogrel Loading and Long-Term Clinical Outcome After Drug-Eluting Stenting for Unprotected Left Main Coronary Disease.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusions-HRPR after 600-mg clopidogrel loading is a strong marker of increased risk of cardiac death and DES thrombosis in patients receiving DES stenting for ULMD. Routine assessment of in vitro residual platelet reactivity after clopidogrel loading in patients with ULMD potentially suitable for DES-supported percutaneous coronary intervention should be considered to guide patient care decisions.
PMID: 19917884 [PubMed - as supplied by publisher]
Source: Circulation - November 16, 2009 Category: Cardiology Authors: Migliorini A, Valenti R, Marcucci R, Parodi G, Giuliani G, Buonamici P, Cerisano G, Carrabba N, Gensini GF, Abbate R, Antoniucci D Tags: Circulation Source Type: journals
B-Type Natriuretic Peptides and Cardiovascular Risk. Systematic Review and Meta-Analysis of 40 Prospective Studies.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusions-Available prospective studies indicate strong associations between circulating concentration of natriuretic peptides and CVD risk under a range of different circumstances. Further investigation is warranted, particularly in large general population studies, to clarify any predictive utility of these markers and to better control for publication bias.
PMID: 19917883 [PubMed - as supplied by publisher]
Source: Circulation - November 16, 2009 Category: Cardiology Authors: Di Angelantonio E, Chowdhury R, Sarwar N, Ray KK, Gobin R, Saleheen D, Thompson A, Gudnason V, Sattar N, Danesh J Tags: Circulation Source Type: journals
Endothelial Progenitor Cells Bind and Inhibit Platelet Function and Thrombus Formation.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusions-Peripheral blood mononuclear cell-derived EPCs bind platelets via CD62P and inhibit platelet activation, aggregation, adhesion to collagen, and thrombus formation, predominantly via upregulation of cyclooxygenase-2 and secretion of prostacyclin. These findings add new insights into the biology of EPCs and define their potential roles in regulating platelet function and thrombosis.
PMID: 19917882 [PubMed - as supplied by publisher]
Source: Circulation - November 16, 2009 Category: Cardiology Authors: Abou-Saleh H, Yacoub D, Théorêt JF, Gillis MA, Neagoe PE, Labarthe B, Théroux P, Sirois MG, Tabrizian M, Thorin E, Merhi Y Tags: Circulation Source Type: journals
Shouldn't Everyone Have an Implantable Cardioverter-Defibrillator?Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
PMID: 19917881 [PubMed - as supplied by publisher]
Source: Circulation - November 16, 2009 Category: Cardiology Authors: Passman R, Kadish A Tags: Circulation Source Type: journals
AHA: Cooling Cardiac Arrest Victims' Brains Before Admission Appears Beneficial (CME/CE)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ORLANDO (MedPage Today) -- Cooling the brain of a person shortly after an out-of-hospital cardiac arrest may improve the chances of survival without brain damage, researchers reported here.
Source: MedPage Today Cardiovascular - November 15, 2009 Category: Cardiology Source Type: news
AHA: Patients Suffering STEMI Fare Better with Ticagrelor Therapy (CME/CE)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ORLANDO (MedPage Today) -- Researchers said that when the investigational platelet aggregation inhibitor ticagrelor was administered to patients with high-risk acute coronary syndromes the outcomes appeared better than treatment with clopidogrel (Plavix) -- a finding that mirrored results on the larger, previously reported study.
Source: MedPage Today Cardiovascular - November 15, 2009 Category: Cardiology Source Type: news
AHA: Radial Artery Better Than Femoral for Cardiac Cath Access (CME/CE)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ORLANDO (MedPage Today) -- Experienced interventional cardiologists at a single center had no problem switching from femoral artery to radial artery access for most procedures in the cath lab, a researcher reported here.
Source: MedPage Today Cardiovascular - November 15, 2009 Category: Cardiology Source Type: news
AHA: Assays Help Predict Risk of Adverse Outcomes After PCI (CME/CE)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ORLANDO (MedPage Today) -- Three tests of platelet reactivity were able to predict which patients undergoing an elective percutaneous coronary intervention would have a thrombotic event within one year, despite antiplatelet therapy, researchers reported here.
Source: MedPage Today Cardiovascular - November 15, 2009 Category: Cardiology Source Type: news
AHA: Biventricular Pacing Prevents Cardiac Remodeling (CME/CE)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Pacing both ventricles of the heart rather than just the right ventricle may prevent declines in left ventricular function for patients with bradycardia but initially normal ejection fraction, researchers found.
Source: MedPage Today Cardiovascular - November 15, 2009 Category: Cardiology Source Type: news
AHA: Ticagrelor bests Plavix in STEMI patients, includes mortality reductionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Orlando, Fla.—STEMI patients who received both aspirin and the new reversible oral antiplatelet drug ticagrelor (Brilinta; AstraZeneca) had few cardiac events and less mortality than patients on aspirin and the popular irreversible antiplatelet medication clopidogrel (Plavix; Bristol-Myers Squibb), based on the results of the PLATO STEMI trial, presented during Sunday’s late-breaking clinical trial session at the American Heart Association conference.
Source: Cardiovascular Business News - November 15, 2009 Category: Cardiology Tags: Latest News Source Type: news
AHA: Postmortem genetic testing may be inexpensive way to ID familial riskEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Orlando, Fla.—Targeted postmortem testing to identify genetic mutations associated with sudden unexplained death (SUD) is an effective and less expensive way to determine risk to relatives than comprehensive cardiac testing of first-degree relatives, according to a study presented Sunday at the 2009 American Heart Association scientific sessions. The researchers also called for more health insurance coverage for these tests.
Source: Cardiovascular Business News - November 15, 2009 Category: Cardiology Tags: Latest News Source Type: news
AHA: Percutaneous aortic valve implantations have high success rateEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Orlando, Fla.--The FRANCE registry, the first registry evaluating both Edwards Lifesciences’ Sapien and Medtronic’s CoreValve bioprosthesis transcatheter aortic valves, showed comparable results between the two valves and the different approaches used, especially in high-risk patients. The data were presented at a late-breaking interventional clinical science session on Saturday at the American Heart Association (AHA) scientific sessions.
Source: Cardiovascular Business News - November 15, 2009 Category: Cardiology Tags: Latest News Source Type: news
CVN: News from AHA 09Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
AHA 2009 Meeting Coverage: Daily Wrap-up / Sunday
Source: Cardiosource - November 15, 2009 Category: Cardiology Source Type: organizations
Experienced operators can switch easily and rapidly to radial access PCI: RAPTOREmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Experienced interventional cardiologists can rapidly shift their practice from the femoral-artery to the radial-access approach, with no increase in procedure time and radiation exposure for PCI. Also, the transradial approach leads to a more economic use of hospital resources, say researchers.
Source: theHeart.org - November 15, 2009 Category: Cardiology Source Type: info
CHAMPION: Negative trials but some positive angles for cangrelor?Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Although neither CHAMPION-PCI nor CHAMPION-PLATFORM showed significant reductions in the primary end point with this new IV antiplatelet agent, some positive effects were seen, suggesting that the drug may yet have a future.
Source: theHeart.org - November 15, 2009 Category: Cardiology Source Type: info
AHA: IV Antiplatelet Drug No CHAMPION (CME/CE)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ORLANDO — The novel fast-acting intravenous antiplatelet agent cangrelor given at the time of PCI or stenting did not reduce the rate of death, MI, or ischemia-driven revascularization at 48 hours compared with clopidogrel (Plavix), results of two trials showed.
Source: MedPage Today Cardiovascular - November 15, 2009 Category: Cardiology Source Type: news
Heart Failure: Proven Treatments Not Always UsedEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Fewer than one-third of patients with heart failure are taking the three types of medications that are most effective in prolonging life and improving quality of life. The November issue of Mayo Clinic Health Letter provides an overview of treatments recommended by national guidelines.
Source: Cardiovascular / Cardiology News From Medical News Today - November 15, 2009 Category: Cardiology Tags: Heart Disease Source Type: news
Heart Disease A 'Silent Killer' In Patients With Severe Mental IllnessEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A large new study confirms that people with severe mental disorders - such as schizophrenia or other psychotic disorders - are 25 percent to 40 percent more prone to die from heart disease than people without mental illness are. Moreover, smoking and physical inactivity - behaviors that individuals potentially can change - significantly contribute to this increased risk of death, found researchers led by Amy Kilbourne, Ph.D.
Source: Cardiovascular / Cardiology News From Medical News Today - November 15, 2009 Category: Cardiology Tags: Heart Disease Source Type: news
New Web Sites Educate About Triglycerides And HDL CholesterolEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Nearly one in three adult Americans have triglyceride (trig) levels that are above normal and nearly 34 million have low HDL "good" cholesterol levels. To help increase awareness about the importance of HDL and trigs, Abbott has launched two Web sites: http://www.knowyourhdl.com and http://www.knowyourtrigs.com.
Source: Cholesterol News From Medical News Today - November 15, 2009 Category: Cardiology Tags: Cholesterol Source Type: news
Cleviprex Results Reported From Study In Patients With Intracerebral HemorrhageEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
First reported interim data from the Evaluation of patients with acute hypertension and intracerebral hemorrhage with intravenous clevidipine treatment (ACCELERATE) trial were presented today at the Neurocritical Care Society (NCS) 2009 Annual Meeting, showing that Cleviprex (clevidipine butyrate) effectively and safely reduces blood pressure in patients with acute, non-traumatic intracerebral hemorrhage (ICH). According to Dr. Carmelo Graffagnino M.D.
Source: Hypertension News From Medical News Today - November 15, 2009 Category: Cardiology Tags: Blood / Hematology Source Type: news
Clinical Trial Summary: Clopidogrel Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition–PLATFORM (CHAMPION PLATFORM — Presented at AHA 2009)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The goal of this trial was to evaluate treatment with intravenous cangrelor compared with placebo among acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI).
Source: Cardiosource - November 15, 2009 Category: Cardiology Source Type: organizations
Undiagnosed AF affects a ‘substantial proportion’ of stroke patientsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Undiagnosed atrial fibrillation is present in nearly 1 in 10 patients with ischemic stroke, a large cohort study has shown.
Source: MedWire News - Cardiology - November 14, 2009 Category: Cardiology Source Type: news
Echocardiographic Contrast Agents: Safe and EfficaciousEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
This commentary discusses the safety of ultrasonic contrast agents and the authors urges their use in echocardiography. AccessMedicine from McGraw-Hill
Source: Medscape Cardiology Headlines - November 14, 2009 Category: Cardiology Tags: Internal Medicine Source Type: info
Zargis To Release Trial Version Of Cardioscan While Exhibiting With 3M(TM) Littmann(R) At American Heart Association ConferenceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Speedus Corp. (Nasdaq: SPDE) announced that it will be releasing a free trial version of its Zargis Cardioscan software during the American Heart Association's 2009 Scientific Sessions conference, taking place this November 15-17 in Orlando.
Source: Cardiovascular / Cardiology News From Medical News Today - November 14, 2009 Category: Cardiology Tags: Cardiovascular / Cardiology Source Type: news
Journal Scan: Revascularization Versus Medical Therapy for Renal-Artery Stenosis (N Engl J Med 2009;361:1953-1962.)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A total of 806 patients with mostly severe atherosclerotic renovascular disease were randomized in a nonblinded fashion to undergo either renal artery revascularization in addition to receiving medical therapy or to receive medical therapy alone. Primary outcome was renal function, as measured by th. . .
Source: Cardiosource - November 14, 2009 Category: Cardiology Source Type: organizations
CardioPulse ArticlesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: European Heart Journal - November 14, 2009 Category: Cardiology Tags: CardioPulse Source Type: journals
EHJ's People's cornerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: European Heart Journal - November 14, 2009 Category: Cardiology Tags: CardioPulse Source Type: journals
Stent thrombosis: who's guilty?Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: European Heart Journal - November 14, 2009 Category: Cardiology Authors: Montalescot, G., Hulot, J.-S., Collet, J.-P. Tags: EDITORIALS Source Type: journals
Not too late, not too fast!!Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: European Heart Journal - November 14, 2009 Category: Cardiology Authors: Leclercq, C., Daubert, C., Mabo, P. Tags: EDITORIALS Source Type: journals
Carotid artery stenting vs. endarterectomyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Randomized clinical trials have demonstrated that carotid endarterectomy (CEA) is superior to medical management for stroke prevention in patients with symptomatic and, to a lesser degree, asymptomatic internal carotid artery stenosis. However, large-scale registries have shown that the adverse event rates following CEA are commonly higher than observed in the trials. In the last decade, carotid artery stenting (CAS) has emerged as a less invasive alternative to surgery. In order to address the efficacy of CAS, we performed a meta-analysis of 10 randomized trials comparing CAS with CEA in 4648 mainly symptomatic patients. ...
Source: European Heart Journal - November 14, 2009 Category: Cardiology Authors: Roffi, M., Mukherjee, D., Clair, D. G. Tags: Controversies in cardiovascular medicine series Source Type: journals
Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trialsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusion
This meta-analysis shows a significant relationship between benefits in mortality from Gp IIb-IIIa inhibitors and patient's risk profile. Thus, Gp IIb-IIIa inhibitors should be strongly considered among high-risk patients.
Source: European Heart Journal - November 14, 2009 Category: Cardiology Authors: De Luca, G., Navarese, E., Marino, P. Tags: Coronary heart disease Source Type: journals
Primary cardiac T-cell lymphoma in a childEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: European Heart Journal - November 14, 2009 Category: Cardiology Authors: Patel, J., Sheppard, M. N. Tags: CARDIOVASCULAR FLASHLIGHTS Source Type: journals
Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year periodEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusion
The 4 year incidence of ST after DES implantation is low. A relevant number of ST occur early after discontinuation of clopidogrel therapy. The dependence of ST on discontinuation of clopidogrel therapy seems to be mostly confined to the first 6 months after DES implantation. However, specifically designed randomized studies are required to establish the optimal length of clopidogrel therapy after DES implantation.
Source: European Heart Journal - November 14, 2009 Category: Cardiology Authors: Schulz, S., Schuster, T., Mehilli, J., Byrne, R. A., Ellert, J., Massberg, S., Goedel, J., Bruskina, O., Ulm, K., Schomig, A., Kastrati, A. Tags: Coronary heart disease Source Type: journals
Severe right bivalvular carcinoid heart diseaseEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: European Heart Journal - November 14, 2009 Category: Cardiology Authors: Jadidi, A. S., Didier, D., Karaca, S., Muller, H. Tags: CARDIOVASCULAR FLASHLIGHTS Source Type: journals
Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusion
Together these data demonstrate that autologous MSCs can be safely delivered in an adult heart failure model, producing substantial structural and functional reverse remodelling. These findings demonstrate the safety and efficacy of autologous MSC therapy and support clinical trials of MSC therapy in patients with chronic ischaemic cardiomyopathy.
Source: European Heart Journal - November 14, 2009 Category: Cardiology Authors: Schuleri, K. H., Feigenbaum, G. S., Centola, M., Weiss, E. S., Zimmet, J. M., Turney, J., Kellner, J., Zviman, M. M., Hatzistergos, K. E., Detrick, B., Conte, J. V., McNiece, I., Steenbergen, C., Lardo, A. C., Hare, J. M. Tags: Coronary heart disease Source Type: journals
Effect of irbesartan and enalapril in non-ST elevation acute coronary syndrome: results of the randomized, double-blind ARCHIPELAGO studyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusion
In patients with NSTEACS, inflammatory markers decreased over time in both treatment arms, with no differences between irbesartan and enalapril.
Source: European Heart Journal - November 14, 2009 Category: Cardiology Authors: Montalescot, G., Drexler, H., Gallo, R., Pearson, T., Thoenes, M., Bhatt, D. L. Tags: Coronary heart disease Source Type: journals
Association between type II secretory phospholipase A2 plasma concentrations and activity and cardiovascular events in patients with coronary heart diseaseEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusion
Secretory phospholipase A2 mass and activity appear to be predictive of secondary CVD events in patients with CHD.
Source: European Heart Journal - November 14, 2009 Category: Cardiology Authors: Koenig, W., Vossen, C. Y., Mallat, Z., Brenner, H., Benessiano, J., Rothenbacher, D. Tags: Coronary heart disease Source Type: journals
Growth differentiation factor-15 predicts mortality and morbidity after cardiac resynchronization therapyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusion
Pre-implant GDF-15 is a strong predictor of mortality and morbidity after CRT, independent of NT pro-BNP. The predictive value of these analytes is enhanced by combined measurement.
Source: European Heart Journal - November 14, 2009 Category: Cardiology Authors: Foley, P. W.X., Stegemann, B., Ng, K., Ramachandran, S., Proudler, A., Frenneaux, M. P., Ng, L. L., Leyva, F. Tags: Heart failure/cardiomyopathy Source Type: journals
A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT [Role of long dEtection window programming in patients with LEft VentriculAr dysfunction, Non-ischemic eTiology in primary prevention treated with a biventricular ICD] studyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusion
A simplified CRT-D device with fixed long detection reduced overall ICD therapy burden and HF hospitalizations without entailing any additional adverse events in primary prevention non-ischaemic HF patients.
Source: European Heart Journal - November 14, 2009 Category: Cardiology Authors: Gasparini, M., Menozzi, C., Proclemer, A., Landolina, M., Iacopino, S., Carboni, A., Lombardo, E., Regoli, F., Biffi, M., Burrone, V., Denaro, A., Boriani, G. Tags: Arrhythmia/electrophysiology Source Type: journals
Severe coronary spasm occasionally detected by coronary computed tomographyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: European Heart Journal - November 14, 2009 Category: Cardiology Authors: Ito, K., Ogawa, T., Yoshimura, M. Tags: CARDIOVASCULAR FLASHLIGHTS Source Type: journals
Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: The Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: European Heart Journal - November 14, 2009 Category: Cardiology Authors: Authors/Task Force Members, Poldermans, D., Bax, J. J., Boersma, E., De Hert, S., Eeckhout, E., Fowkes, G., Gorenek, B., Hennerici, M. G., Iung, B., Kelm, M., Kjeldsen, K. P., Kristensen, S. D., Lopez-Sendon, J., Pelosi, P., Philippe, F., Pierard, L., Pon Tags: ESC GUIDELINES Source Type: journals
C-reactive protein: not only a marker but also a mediator of myocardial damage following acute myocardial infarctionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: European Heart Journal - November 14, 2009 Category: Cardiology Authors: Celik, T. Tags: LETTERS TO THE EDITOR Source Type: journals
